During the past decade, Avamar Center for Endoscopy conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Avamar Center for Endoscopy" #1 collaborator was "GlaxoSmithKline" with 1 trials as a collaborator and "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Avamar Center for Endoscopy" are "Ulcerative Colitis" (3 trials) and "Inflammatory Bowel Disease" (2 trials). Many other conditions were trialed in "Avamar Center for Endoscopy" in a lesser frequency.

Most popular intervention types in "Avamar Center for Endoscopy" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Balsalazide Disodium" (1 trials), "Encapsulated Mesalamine Granules (eMG)" (1 trials), "Placebo" (1 trials) and "Rosiglitazone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Avamar Center for Endoscopy" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Avamar Center for Endoscopy". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Avamar Center for Endoscopy, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Avamar Center for Endoscopy, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".